Robert J. Terifay
2013
In 2013, Robert J. Terifay earned a total compensation of $7.7M as Executive Vice President, Commercial at Regeneron Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Bonus | $364,500 |
|---|---|
| Option Awards | $6,847,486 |
| Salary | $450,000 |
| Other | $17,145 |
| Total | $7,679,131 |
Terifay received $6.8M in option awards, accounting for 89% of the total pay in 2013.
Terifay also received $364.5K in bonus, $450K in salary and $17.1K in other compensation.
Rankings
In 2013, Robert J. Terifay's compensation ranked 675th out of 12,286 executives tracked by ExecPay. In other words, Terifay earned more than 94.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 675 out of 12,286 | 95th |
Division Manufacturing | 223 out of 4,614 | 95th |
Major group Chemicals And Allied Products | 56 out of 1,466 | 96th |
Industry group Drugs | 35 out of 1,160 | 97th |
Industry Pharmaceutical Preparations | 32 out of 890 | 96th |
Source: SEC filing on April 26, 2016.
Terifay's colleagues
We found five more compensation records of executives who worked with Robert J. Terifay at Regeneron Pharmaceuticals in 2013.
2013
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2013
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2013
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
2013
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2013
Murray Goldberg
Regeneron Pharmaceuticals